Sioot - Società Scientifica di Ossigeno-Ozono Terapia
Italiano
MENU  

Speciale covid 19


Perché SIOOT ha pensato per prima al mondo a un protocollo di Ossigeno Ozono Terapia efficace nel trattamento del Covid19?

Questa è una doverosa opportunità da non perdere per realizzare una terapia sempre più efficace, tramite un protocollo di pratica medica stilato della Società Scientifica di Ossigeno Ozono Terapia:
1. L’ossigeno Ozono Terapia è una pratica medica (non farmaco) empirica ragionata e suffragata da una cospicua bibliografia.
2. Utile a raggiungere una inattivazione del virus
3. Attivare il sistema immunitario cellulare e umorale
4. Ridurre i processi d’infiammazione/apoptosi e favorire le vie molecolari dello stress antiossidativo
5. Correggere in breve l’ipossia prevenendo problemi vascolari

Il protocollo SIOOT si sta dimostrando come l’unica vera risposta al Covid19, efficace e senza controindicazioni.

24/10/2022
COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An overview

Background: Italy accounts for more than 150,000 deaths due to the COVID-19 pandemic, leading the top rank in SARS-CoV-2-caused deceases in Europe. A survey on the different ways by which the COVID-19 pandemic emergency was managed in the foreign European countries compared to Italy is the purpose of this paper. (2) Methods: A literature search and [ continua... ]

24/10/2022
Seasonality of COVID-19 deaths. Did social restrictions and vaccination actually impact the official reported dynamic of COVID-19 pandemic in Italy?

A recent contribution in this journal on a comparative investigation, performed between two different time intervals (April–September in 2020 and 2021), reported that the distribution of COVID-19 confirmed cases, hospitalization of positive patients and admission in the intensive care units (ICUs) in Italy, did not show any significant reduction in [ continua... ]

24/10/2022
Escaping from COVID-19 emergency accounting on previously infected subjects?

In a recent paper, some authors wondered if the COVID‐19 pandemic will end with the Omicron (B.1.1.529) and Delta (B.1.617.2) variants.1 The variant of concern (VoC) Omicron is characterized by few some deletions and more than 30 mutations, several of which (e.g., 69–70del, T95I, G142D/143–145del, K417N, T478K, N501Y, N655Y, N679K, and P681H) [ continua... ]

24/10/2022
Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal

The COVID-19 pandemic is a highly dramatic concern for mankind. In Italy, the pandemic exerted its major impact throughout the period of February to June 2020. To date, the awkward amount of more than 134,000 deaths has been reported. Yet, post-mortem autopsy was performed on a very modest number of patients who died from COVID-19 infection, [ continua... ]

24/10/2022
The biological activity of medical ozone in the hormetic range and the role of full axpertise professionals

The recent paper by Cenci et al. (1) provided us with an overview of the biological action of medical ozone (O3) on infectious agents, with a particular focus on its antiviral activity. Ozone is an allotrope of oxygen, a triatomic oxygen molecule that recently showed an ability to counteract the progress of COVID-19 and the development of [ continua... ]

24/10/2022
SJOGREN SYNDROME SUCCESSFULLY TREATED WITH OXYGEN-OZONE AUTO-HEMOTHERAPY

Sjögren syndrome (SS) is an autoimmune disorder, affecting about 16,000 individuals in Italy, yet lacking a standardized therapy protocol and a plain inclusion in the reimbursed healthcare services. This raises many controversial issues about how managing the SS patient, to relief pain and discomfort and improve patients’ health and social life.The [ continua... ]

24/10/2022
The role of antioxidants in the Interplay between Oxidative Stress and senescence. Antioxidants

Cellular senescence is an irreversible state of cell cycle arrest occurring in response to stressful stimuli, such as telomere attrition, DNA damage, reactive oxygen species, and oncogenic proteins. Although beneficial and protective in several physiological processes, an excessive senescent cell burden has been involved in various pathological [ continua... ]

24/10/2022
Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression

Alzheimer’s Disease (AD) is a progressive neurodegenerative disease characterized by amyloid- (A ) plaque deposition and neurofibrillary tangle accumulation in the brain. Although several studies have been conducted to unravel the complex and interconnected pathophysiology of AD, clinical trial failure rates have been high, and no [ continua... ]

24/10/2022
A practical assessment to prevent serious complications in the use of a gaseous miture of oxygen-ozone injected by needle-mediates infiltration

consideration. What is true is that using ozone as an immune-pharmaceutical active substance may lead to severe adverse effects, if the physician’s expertise is not fully trained. In this respect, some authors recently outlined the dangerousness of using ozone in medical practice. In their opinion, ozone may be toxic for the central nervous system [ continua... ]

24/10/2022
COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview

Background: Italy accounts for more than 150,000 deaths due to the COVID-19 pandemic, leading the top rank in SARS-CoV-2-caused deceases in Europe. A survey on the different ways by which the COVID-19 pandemic emergency was managed in the foreign European countries compared to Italy is the purpose of this paper. (2) Methods: A literature search and [ continua... ]

24/10/2022
Seasonality of COVID-19 deaths. Did social restrictions and vaccination actually impact the official reported dynamic of COVID-19 pandemic in Italy?

A recent contribution in this journal on a comparative investigation, performed between two different time intervals (April–September in 2020 and 2021), reported that the distribution of COVID-19 confirmed cases, hospitalization of positive patients and admission in the intensive care units (ICUs) in Italy, did not show any significant reduction in [ continua... ]

24/10/2022
Integrating medical knowledge to improve science with a novel, straightforward attitude: the bio-integrative medicine

Progressing on the scientific pathway should mean accounting on a pluralistic attitude and on a rigorous approach to deal with any natural event occurring in the human life. Progressing means describing, interpreting and addressing the phenomena with the exclusive tools of rationality, experimental trials and criticism in the widest debate expanded [ continua... ]

24/10/2022
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment

Gut microbiota is emerging as a key regulator of many disease conditions and its dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal disorders. More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the [ continua... ]

24/10/2022
Escaping from COVID‐19 emergency accounting on previously infected subjects?

In a recent paper, some authors wondered if the COVID‐19 pandemic will end with the Omicron (B.1.1.529) and Delta (B.1.617.2) variants.1 The variant of concern (VoC) Omicron is characterized by few some deletions and more than 30 mutations, several of which (e.g., 69–70del, T95I, G142D/143–145del, K417N, T478K, N501Y, N655Y, N679K, and P681H) [ continua... ]

24/10/2022
Male vs. Female Differences in Responding to Oxygen–Ozone Autohemotherapy (O2-O3-AHT) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a syndrome that has fatigue as its major symptom. Evidence suggests that ozone is able to relieve ME/CFS-related fatigue in affected patients. (2) Objective: To evaluate whether differences exist between males and females in ozone therapy outputs in ME/CFS. (3) Methods: In [ continua... ]